leadf
logo-loader
viewDelta 9 Cannabis Inc.

Delta 9 Cannabis achieves final services milestone in support of partner F1NE Cannabis Cultivation’s micro cultivation licenses

F1NE Cannabis Cultivation has received a Health Canada Licence for Delta 9's proprietary and turnkey Grow Pod systems

Delta 9 Cannabis Inc. -
Delta 9 said it has now successfully licensed more than 100 Grow Pods in third-party facilities across Canada

Delta 9 Cannabis Inc (TSE:DN) (OTCQX:VRNDF) (FRA:V5D1) announced it has completed the final services milestone in its agreement with partner F1NE Cannabis Cultivation Ltd (F1), which resulted in F1 receiving its cannabis micro cultivation licenses from Health Canada. 

Delta 9 said it has provided services to F1 as part of a Strategic Cooperation Agreement (SCA) related to cannabis production, development of standard operating procedures and sanitation programs, consulting on Health Canada licensing, marketing services, brand development and other services supporting the acquisition of the Health Canada license. 

“We are delighted that F1NE Cannabis Cultivation has received a Health Canada Licence for our proprietary and turnkey Grow Pod systems,” Delta 9 Cannabis CEO John Arbuthnot said in a statement. 

READ: Delta 9 Cannabis focused on bringing the highest quality cannabis products to market

He added: “Our turnkey platform for Grow Pods and services continues to prove one of the best options for cannabis industry entrepreneurs seeking licensing and support services.”

Delta 9 noted that its cannabis production methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which resemble retrofitted 40-foot shipping containers.

The company provides vertical growing units, integrated grow racks, and LED grow lights, part of non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and automated fertigation and watering systems, which is developed using precision hardware and software grow applications for the indoor cannabis cultivation marketplace.

Delta 9 added that it plans to purchase cannabis products from F1 for distribution through its established distribution network, and through Delta 9's branded retail stores.

Delta 9 said it has now successfully licensed more than 100 Grow Pods in third-party facilities across Canada.   

Delta 9 Cannabis is a vertically-integrated cannabis company focused on bringing the highest quality cannabis products to market. The company sells cannabis products through its wholesale and retail sales channels and sells its cannabis 'Grow Pods' to other businesses.

The company's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 also owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.

Contact Sean at sean@proactiveinvestors.com

Quick facts: Delta 9 Cannabis Inc.

Price: 0.58 CAD

TSX:DN
Market: TSX
Market Cap: $59.13 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Delta 9 Cannabis Inc. named herein, including the promotion by the Company of Delta 9 Cannabis Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Delta 9 Cannabis CEO reveals record $14.2M in revenue for 4Q, with plans to...

Delta 9 Cannabis Inc (TSE:DN) (OTCQX:DLNTF) CEOJohn Arbuthnot tells Proactive the Winnipeg-based group posted strong quarterly and year-end results including a company-record 4Q revenue of $14.2 million and $52 million for the year. Arbuthnot says the quarterly figure was a 34% increase compared...

2 weeks ago

2 min read